Literature DB >> 5352841

The coincidence of neuroblastoma and acute cerebellar encephalopathy.

P F Bray, F A Ziter, M E Lahey, G G Myers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5352841     DOI: 10.1016/s0022-3476(69)80335-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  13 in total

Review 1.  A review of the therapy of paraneoplastic neurologic syndromes.

Authors:  A Das; F H Hochberg; S McNelis
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

Review 2.  Neuroblastoma as a neurobiological disease.

Authors:  N F Schor
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

3.  Opsoclonus, myoclonus, ataxia and occult neuroblastoma (neuroblastoma-encephalopathy).

Authors:  B O Berg
Journal:  West J Med       Date:  1974-06

4.  Neurological sequelae of the dancing eye syndrome.

Authors:  K R Pohl; J Pritchard; J Wilson
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

Review 5.  The remote effects of cancer on the nervous system.

Authors:  F H Norris
Journal:  Z Neurol       Date:  1972

6.  Acute cerebellar encephalopathy as a remote complication of neuroblastoma.

Authors:  P F Bray
Journal:  Calif Med       Date:  1972-08

7.  Cerebellar ataxia. Anatomical, physiological and clinical implications.

Authors:  P M Dreyfus; M Oshtory; E D Gardner; J S Lieberman; N Vijayan
Journal:  West J Med       Date:  1978-06

8.  Presenting features of thoracic neuroblastoma.

Authors:  G R McLatchie; D G Young
Journal:  Arch Dis Child       Date:  1980-12       Impact factor: 3.791

9.  St. Louis encephalitis in children.

Authors:  A M Kaplan; W L Longhurst; D L Randall
Journal:  West J Med       Date:  1978-04

10.  Opsoclonus-myoclonus syndrome: correlation of radiographic and pathological observations.

Authors:  R F Tuchman; L A Alvarez; A B Kantrowitz; F G Moser; J Llena; S L Moshé
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.